title: Gynaecomastia during antituberculosis chemotherapy with isoniazid.
authors.forename: Ramakant
authors.initials: R
authors.lastname: Dixit
authors.forename: Sidharth
authors.initials: S
authors.lastname: Sharma
authors.forename: C L
authors.initials: CL
authors.lastname: Nawal
mesh_terms: D000328:Adult; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006177:Gynecomastia / Q000188:drug therapy*; D006801:Humans; D007194:India; D007538:Isoniazid / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D011718:Pyrazinamide / Q000008:administration & dosage / Q000009:adverse effects; D012293:Rifampin / Q000008:administration & dosage / Q000009:adverse effects; D014388:Tuberculosis, Lymph Node / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin